Israel’s SuperDimension Device Maker Attracts $300 Million Covidien Bid
This article was originally published in PharmAsia News
Executive Summary
Israel’s SuperDimension has been offered $300 million by Ireland-base device maker Covidien for access to two devices designed for minimally invasive surgery.